Der Browser den Sie verwenden ist sehr alt.

Wir können daher nicht sicherstellen, dass jede Funktion (Gestaltung, Bilder und zusätzliche Funktionen) dieser Internetseite im vollen Umfang zur Verfügung steht. Bitte nutzen Sie eine aktuellere Browserversion.
Wir bitten um Ihr Verständnis.
Startseite > Forschung > Neuroimmunologie > Publikationsliste

Publikationen

2019

Schuster S, Abrante L, Matschke J, Lütgehetmann M, Holst B, Gelderblom M, Braass H, Leypoldt F, Magnus T: (2019) Fatal PCR-negative herpes simplex virus-1 encephalitis with GABA(A) receptor antibodies Neurol Neuroimmunol Neuroinflamm. 2019 Sep 25;6(6):e624. doi: 10.1212/NXI.0000000000000624. Print 2019 Nov.

Lamby N, Leypoldt F, Schulz JB, Tauber SC: (2019) Atypical presentation of anti-Ma2-associated encephalitis with choreiform movement Neurol Neuroimmunol Neuroinflamm. 2019 Apr 1;6(3):e557. doi: 10.1212/NXI.0000000000000557. eCollection 2019 May.

Endres D, Bechter K, Prüss H, Hasan A, Steiner J, Leypoldt F, Tebartz van Elst L: (2019) [Autoantibody-associated schizophreniform psychoses: clinical symptomatology] Nervenarzt. 2019 May;90(5):547-563. doi: 10.1007/s00115-019-0700-z.

Tebartz van Elst L, Bechter K, Prüss H, Hasan A, Steiner JH, Leypoldt F, Endres D: (2019) [Autoantibody-associated schizophreniform psychoses: pathophysiology, diagnostics, and treatment] Nervenarzt. 2019 Jul;90(7):745-761. doi: 10.1007/s00115-019-0735-1.

Rempe T, Becktepe JS, Metz I, Brück W, Stürner KH, Deuschl G, Berg D, Baron R, Zeuner R, Leypoldt F: (2019) A case of CLIPPERS syndrome responsive to tocilizumab Neurol Neuroimmunol Neuroinflamm. 2019 Feb 1;6(3):e545. doi: 10.1212/NXI.0000000000000545. eCollection 2019 May.

Gold SM, Willing A, Leypoldt F, Paul F, Friese MA: (2019) Sex differences in autoimmune disorders of the central nervous system Semin Immunopathol. 2019 Mar;41(2):177-188. doi: 10.1007/s00281-018-0723-8. Epub 2018 Oct 25.

Baumgartner A, Rauer S, Hottenrott T, Leypoldt F, Ufer F, Hegen H, Prüss H, Lewerenz J, Deisenhammer F, Stich O. (2019) Admission diagnoses of patients later diagnosed with autoimmune encephalitis J Neurol. 2019 Jan;266(1):124-132. doi: 10.1007/s00415-018-9105-3. Epub 2018 Nov 12.

Lieb W, Jacobs G, Wolf A, Richter G, Gaede KI, Schwarz J, Arnold N, Böhm R, Buyx A, Cascorbi I, Franke A, Glinicke C, Held-Feindt J, Junker R, Kalthoff H, Kramer HH, Leypoldt F, Maass N, Maetzler W, May S, Mehdorn HM, Röcken C, Schafmayer C, Schrappe M, Schreiber S, Sebens S, Stephani U, Synowitz M, Weimer J, Zabel P, Nöthlings U, Röder C, Krawczak M. (2019) Linking pre-existing biorepositories for medical research: the PopGen 2.0 Network J Community Genet. 2019 Oct;10(4):523-530. doi: 10.1007/s12687-019-00417-8. Epub 2019 Mar 29.

Hopfner F, Müller SH, Steppat D, Miller J, Schmidt N, Wandinger KP, Leypoldt F, Berg D, Franke A, Lieb W, Tittmann L, Balzer-Geldsetzer M, Baudrexel S, Dodel R, Hilker-Roggendorf R, Kalbe E, Kassubek J, Klockgether T, Liepelt-Scarfone I, Mollenhauer B, Neuser P, Reetz K, Riedel O, Schulte C, Schulz JB, Spottke A, Storch A, Trenkwalder C, Wittchen HU, Witt K, Wüllner U, Deuschl G, Kuhlenbäumer G. (2019) No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors Transl Neurodegener. 2019 Apr 3;8:11. doi: 10.1186/s40035-019-0153-0. eCollection 2019.

Stengel H, Vural A, Brunder AM, Heinius A, Appeltshauser L, Fiebig B, Giese F, Dresel C, Papagianni A, Birklein F, Weis J, Huchtemann T, Schmidt C, Körtvelyessy P, Villmann C, Meinl E, Sommer C, Leypoldt F*, Doppler K*. (2019) Anti-pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy Neurol Neuroimmunol Neuroinflamm. 2019 Aug 16;6(5):e603. doi: 10.1212/NXI.0000000000000603. Print 2019 Sep. *equally contributing

Bartsch T, Rempe T, Leypoldt F, Riedel C, Jansen O, Berg D, Deuschl G. (2019) The spectrum of progressive multifocal leukoencephalopathy: a practical approach Eur J Neurol. 2019 Apr;26(4):566-e41. doi: 10.1111/ene.13906. Epub 2019 Feb 8.

Dalmau J, Armangué T, Planagumà J, Radosevic M, Mannara F, Leypoldt F, Geis C, Lancaster E, Titulaer MJ, Rosenfeld MR, Graus F. (2019) An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models Lancet Neurol. 2019 Nov;18(11):1045-1057. doi: 10.1016/S1474-4422(19)30244-3. Epub 2019 Jul 17.

Laudes, M, Frohnert, J, Ivanova, K, Wandinger, KP (2019) PTH immunoassay interference due to human anti-mouse antibodies in an obese human subject with normal parathyroid function. J. Clin. Endocrinol. Metab. 104:5840-5842

Royl, G, Fokou, T F, Chunder, R, Isa, R, Münte, T F, Wandinger, K P, Schwaninger, M, Herrmann, O, Valdueza, J M, Brocke, J, Willkomm, M, Willemsen, D, Auffarth, G U, Mindorf, S, Brix, B, Chamorro, Planas, A, Urra, X: Antibodies against neural antigens in patients with acute stroke: joint results of three independent cohort studies. J. Neurol. 266:2772-2779

Koch, H, Niturad, C.E, Theiss, S, Bien, C.G, Elger, C, Wandinger, KP, Vincent, A., Malter, M., Körtvélyessy, P., Lerche, H., Dihné, M: In vitro neuronal network activity as a new functional diagnostic system to detect effects of cerebrospinal fluid from autoimmune encephalitis patients. Sci. Rep. Apr 3;9:5591 doi: 10.1038/s41598-019-41849-z

Wagner-Altendorf, TA, Wandinger, KP, Frydrychowicz, A, Merseburger, A, Münte, TF: Amphiphysin-associated limbic encephalitis in a 72-year old individual with aortal angiosarcoma. BMJ Case Reports Mar 14;12 doi: 10.1136/bcr-2018-226798

Borsche, M, Hahn, S, Hanssen, H, Münchau, A, Wandinger, KP, Brüggemann, N: Sez6l2-antibody-associated progressive cerebellar ataxia - a differential diagnosis of atypical parkinsonism. J. Neurol. 266:522-524; doi: 10.1007/s00415-018-9115-1

2018

Borsche M, Hahn S, Hanßen H, Münchau A, Wandinger KP, Brüggemann N: Sez6l2-antibody-associated progressive cerebellar ataxia - a differential diagnosis of atypical parkinsonism. J. Neurol. doi: 10.1007/s00415-018-9115-1

Hasselbacher K, Steffen A, Wandinger KP: Brüggemann N: IgLON5 antibodies are infrequent in patients with isolated sleep apnea. Eur J Neurol 2018; 25: e46-e47. doi: 10.1111/ene.13566.

Moser A, Hanssen H, Wandinger KP: Excessively increased CSF glutamate levels in GABAB-receptor antibody associated encephalitis: A case report. J Neurol Sci 2018; 388: 10-11. 

Prasuhn J, Royl G, Wandinger KP, Brüggemann N, Neumann A, Münte TF: Transient generalized chorea-athethosis in influenza A encephalopathy: Tremor Other Hyperkinet. Mov. doi: 10.7916/D8F495TP

Heine J, Prüss H, Kopp UA, Wegner F, Then Bergh F, Münte T, Wandinger KP, Paul F, Bartsch T, Finke C: Beyond the limbic system: disruption and functional compensation of large-scale brain networks in patients with anti-LGI1 encephalitis. J Neurol Neurosurg Psychiatry 2018; pii: jnnp-2017-317780. doi: 10.1136/jnnp-2017-317780. Epub 2018 Jun 9.

Wandinger KP, Leypoldt F, Junker R: Autoantibody-associated encephalitis. Deut Ärzteblatt 2018; 115: 666-673.

Leypoldt F, Junker R, Wandinger KP: Hightech im Labor – Neuronale Autoantikörper ermöglichen den Nachweis bislang unbekannter Krankheitsbilder. Management & Krankenhaus Sonderheft kompakt 2018; 9:26.

Mueller SH, Färber A, Prüss H, Melzer N, Golombeck KS, Kümpfel T, Thaler F, Elisak M, Lewerenz J, Kaufmann M, Sühs KW, Ringelstein M, Kellinghaus C, Bien CG, Kraft A, Zettl UK, Ehrlich S, Handreka R, Rostásy K, Then Bergh F, Faiss JH, Lieb W, Franke A, Kuhlenbäumer G, Wandinger KP, Leypoldt F, German Network for Research on Autoimmune Encephalitis (GENERATE): Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis. Ann Neurol 2018; 83: 863-69.

Dulovic M, Schäffer E, Leypoldt F, Balck A, Schaake S, Hinrichs F, Kirchner H, Brüggemann N, Berg D, Lohmann K: A Klinefelter patient with an additional mitochondrial mutation: Implications for genotype-driven treatment and mitochondrial mutational load in different tissues and family members. Parkinsonism Relat Disord 2018; pii: S1353-8020(18)30146-9. doi: 10.1016/j.parkreldis.2018.04.001. Epub 2018 Apr 3.

Jarius S, Ruprecht K, Stellmann JP, Huss A, Ayzenberg I, Willing A, Trebst C, Pawlitzki M, Abdelhak A, Grüter T, Leypoldt F, Haas J, Kleiter I, Tumani H, Fechner K, Reindl M, Paul F, Wildemann B: MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature. J Neuroinflammation 2018; 15: 88. "

Pawlitzki M, Schreiber S, Bittner D, Kreipe J, Leypoldt F, Rupprecht K, Carare RO, Meuth SG, Vielhaber S, Körtvélyessy P: CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration. Front Neurol. 2018 Dec 14;9:1037. doi: 10.3389/fneur.2018.01037. eCollection 2018.

Schubert J, Brämer D, Huttner HB, Gerner ST, Fuhrer H, Melzer N, Dik A, Prüss H, Ly LT, Fuchs K, Leypoldt F, Nissen G, Schirotzek I, Dohmen C, Bösel J, Lewerenz J, Thaler F, Kraft A, Juranek A, Ringelstein M, Sühs KW, Urbanek C, Scherag A, Geis C, Witte OW, Günther A; GENERATE and IGNITE network: Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment. Neurol Neuroimmunol Neuroinflamm. 2018 Oct 30;6(1):e514. doi: 10.1212/NXI.0000000000000514. eCollection 2019 Jan.

Yilmaz R, Strafella AP, Bernard A, Schulte C, van den Heuvel L, Schneiderhan-Marra N, Knorpp T, Joos TO, Leypoldt F, Geritz J, Hansen C, Heinzel S, Apel A, Gasser T, Lang AE, Berg D, Maetzler W, Marras C: Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease. Front Neurol. 2018 Dec 21;9:1123. doi: 10.3389/fneur.2018.01123. eCollection 2018.

Elisak M, Krysl D, Hanzalova J, Volna K, Bien CG, Leypoldt F, Marusic P. The prevalence of neural antibodies in temporal lobe epilepsy and the clinical characteristics of seropositive patients. Seizure. 2018 Dec;63:1-6. doi: 10.1016/j.seizure.2018.09.009. Epub 2018 Sep 17.

Gold SM, Willing A, Leypoldt F, Paul F, Friese MA: Sex differences in autoimmune disorders of the central nervous system. Semin Immunopathol. 2018 Oct 25. doi: 10.1007/s00281-018-0723-8. [Epub ahead of print]

Körtvelyessy P, Prüss H, Thurner L, Maetzler W, Vittore-Welliong D, Schultze-Amberger J, Heinze HJ, Reinhold D, Leypoldt F, Schreiber S, Bittner D: Biomarkers of Neurodegeneration in Autoimmune-Mediated Encephalitis. Front Neurol. 2018 Sep 19;9:668. doi: 10.3389/fneur.2018.00668. eCollection 2018 PMID: 30283395

2017

Körtvélyessy P, Breu M, Pawlitzki M, Metz I, Heinze HJ, Matzke M, Mawrin C, Rommer P, Kovacs GG, Mitter C, Reindl M, Brück W, Wandinger KP, Lassmann H, Höftberger R, Leypoldt F: ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports. Neurol Neuroimmunol Neuroinflamm 2017; 4: e335.  doi: 10.1212/NXI.0000000000000335. eCollection 2017 May.

Miske R, Gross CC, Scharf M, Golombeck KS, Hartwig M, Bhatia U, Schulte-Mecklenbeck A, Bönte K, Strippel C, Schöls L, Synofzik M, Lohmann H, Dettman IM, Deppe M, Mindorf S, Warnecke T, Denno Y, Teegen B, Probst C, Brakopp S, Wandinger KP, Wiendl H, Stöcker W, Meuth SG, Komorowski L, Melzer N: Neurochondrin is a neuronal target antigen in autoimmune cerebellar degeneration. Neurol Neuroimmunol Neuroinflamm 2017; 4: e307.

Finke C, Prüss H, Heine J, Reuter S, Kopp UA, Wegner F, Then Bergh F, Koch S, Jansen O, Münte, Deuschl G, Ruprecht K, Stöcker W, Wandinger KP, Paul F, Bartsch T: Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis with Leicine. Rich, Glioma-Inactivated 1 Antibodies. JAMA Neurol 2017; 74: 50-9.

Haussleiter IS, Wandinger KP, Juckel G: A case of GABAR antibodies in schizophrenia. BMC Psychiatry 2017; 17: 9.

Malviya M, Barman S, Golombeck KS, Planagumà J, Mannara F, Strutz-Seebohm N, Wrzos C, Demir F, Baksmeier C, Steckel J, Falk KK, Gross CC, Kovac S, Bönte K, Johnen A, Wandinger KP, Martín-García E, Becker AJ, Elger CE, Klöcker N, Wiendl H, Meuth SG, Hartung HP, Seebohm G, Leypoldt F, Maldonado R, Stadelmann C, Dalmau J, Melzer N, Goebels N: NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody. Ann Clin Trans Neurol 2017; 4: 768-83.

Hahn S, Trendelenburg G, Scharf M, Denno Y, Brakopp S, Teegen B, Probst C, Wandinger KP, Buttmann M, Haarmann A, Szabados F, vom Dahl M, Kümpfel T, Eichhorn P, Gold HJ, Paul, F, Jarius S, Melzer N, Stöcker W, Komorowsk L: Identification of the flotilin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis. J Neuroinflamm 2017; 14: 123.

Ludwig RJ, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, McLachlan S, Komorowski L, Luo J, Marques O, Hammers CM, Lindstrom JM, Lamprecht P, Fischer A, Riemekasten G, Tersteeg C, Sondermann P, Rapoport B, Wandinger KP, Probst C, El Beidaq A, Schmidt E, Verkman A, Manz RA, Nimmerjahn F. Mechanisms of autoantibody-induced pathology. Front Immunol 2017; 8: 603.

Hennes EM, Baumann M, Schanda K, Anlar B, Bajer-Kornek B, Blaschek A, Brantner-Inthaler S, Diepold K, Eisenkölbl A, Gotwald T, Kuchukhidze G, Gruber-Sedlmayr U, Häusler M, Höftberger R, Karenfort M, Klein A, Koch J, Kraus V, Lechner C, Leiz S, Leypoldt F, Mader S, Marquard K, Poggenburg I, Pohl D, Pritsch M, Raucherzauner M, Schimmel M, Thiels C, Tibussek D, Vieker S, Zeches C, Berger T, Reindl M, Rostásy K, BIOMARKER Study Group: Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology 2017; 89: 900-8.

Gaig C, Graus F, Compta Y, Högl B, Bataller L, Brüggemann N, Giordana C, Heidbreder A, Kotschet K, Lewerenz J, Macher S, Marti  MJ, Montojo T, Perez-Perez J, Puertas , Seitz C, Simabukur M, Tellez N, Wandinger KP, Iranzo A, Ercilla G, Sabater L, Santamaria J, Dalmau J: Clinical manifestations of the anti-IgLON5 disease. Neurology 2017; 88: 1746-3.

Koch M, Furtado JD, Falk K, Leypoldt F, Mukamal KJ, Jensen MK: Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma. Alzheimers Dement (Amst) 2017; 6: 182-7. 

Finke C, Prüss H, Heine J, Reuter S, Kopp U, Wegner F, Berg F, Koch S, Jansen O, Münte T, Deuschl G, Ruprecht K, Stöcker W, Wandinger KP, Paul F, Bartsch T:  Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma inactivated 1 antibodies. JAMA Neurol 2017; 74: 50-9.

Leypoldt F, Magnus, T, Voltz R: Paraneoplastische neurologische Syndrome In: Diener, Gerloff, Dieterich: Therapie und Verlauf neurologischer Erkrankungen. Stuttgart: Kohlhammer 2017; 979-989..

2016

Gersing A.S., Faymonville A.M,. Schwaiger B.J., Leypoldt F., Siemonsen S., Zimmer C., Magnus T., Fiehler J. Quantitative T2* mapping reveals early temporo-spatial dynamics in an ischemic stroke model. J. Neurosci. Methods. 2016 Feb 1;259:83-9. doi: 10.1016/j.jneumeth.2015.11.018. Epub 2015 Nov 29.

Graus F., Titulaer M.J., Balu R., Benseler S., Bien C.G., Cellucci T., Cortese I., Dale R.C., Gelfand J.M., Geschwind M., Glaser C.A., Honnorat J., Höftberger R., Iizuka T., Irani S.R., Lancaster E., Leypoldt F., Prüss H., Rae-Grant A., Reindl M., Rosenfeld M.R., Rostásy K., Saiz A., Venkatesan A., Vincent A., Wandinger K.P., Waters P., Dalmau J. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016 Apr;15(4):391-404. doi: 10.1016/S1474-4422(15)00401-9

Gövert F., Witt K., Erro R., Hellriegel H., Paschen S., Martinez-Hernandez E., Wandinger K.P., Deuschl G., Dalmau J., Leypoldt F. Orthostatic myoclonus associated with Caspr2 antibodies. Neurology. 2016 Apr 5;86(14):1353-5. doi: 10.1212/WNL.0000000000002547

Erdur H., Scholz V., Streitz M., Hammer M., Meisel C., Schönemann C., Wandinger K.P., Rosche B. EBNA1 antigen-specific CD8+ Tcells in cerebrospinal fluid of patients with multiple sclerosis. J. Neuroimmunol. 2016 May 15;294:14-7. doi: 10.1016/j.jneuroim.2016.03.010. Epub 2016 Mar 19.

Brüggemann N., Wandinger K.P., Gaig C., Sprenger A., Junghanns K., Helmchen C., Münchau A. Dystonia, lower limb stiffness, and upward gaze palsy in a patient with IgLON5 antibodies. Mov. Disord. 2016 May;31(5):762-4. doi: 10.1002/mds.26608. Epub 2016 Mar 31.

van Sonderen A., Ariño H., Petit-Pedrol M., Leypoldt F., Körtvélyessy P., Wandinger K.P., Lancaster E., Wirtz P.W., Schreurs M.W., Sillevis Smitt P.A., Graus F., Dalmau J., Titulaer M.J. The clinical spectrum of Caspr2 antibody-associated disease. Neurology. 2016 Aug 2;87(5):521-8. doi: 10.1212/WNL.0000000000002917.

Lechner C., Baumann M., Hennes E.M., Schanda K., Marquard K., Karenfort M., Leiz S., Pohl D., Venkateswaran S., Pritsch M., Koch J., Schimmel M., Häusler M., Klein A., Blaschek A., Thiels C., Lücke T., Gruber-Sedlmayr U., Kornek B., Hahn A., Leypoldt F., Sandrieser T., Gallwitz H., Stoffels J., Korenke C., Reindl M., Rostásy K. Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease. J. Neurol. Neurosurg. Psychiatry. 2016 Aug;87(8):897-905. doi: 10.1136/jnnp-2015-311743. Epub 2015 Dec 8.

van Gerpen J.A., Ahlskog J.E., Chen R., Fung V.S., Hallett M., Gövert F., Deuschl G., Leypoldt F. Orthostatic myoclonus associated with Caspr2 antibodies. Neurology. 2016 Sep 13;87(11):1187-8. doi: 10.1212/WNL.0000000000003140.

Jarius S., Ringelstein M., Haas J., Serysheva I.I., Komorowski L., Fechner K., Wandinger K.P., Albrecht P., Hefter H., Moser A., Neuen-Jacob E., Hartung H.P., Wildemann B., Aktas O. Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy. J Neuroinflammation. 2016 Oct 24;13(1):278.

Finke C., Prüss H., Heine J., Reuter S., Kopp U.A., Wegner F., Then Bergh F., Koch S., Jansen O., Münte T., Deuschl G., Ruprecht K., Stöcker W., Wandinger K.P., Paul .F, Bartsch T. Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis with Leicine.Rich, Glioma-Inactivated 1 Antibodies. JAMA Neurol. 2016 Nov 21. doi: 10.1001/jamaneurol.2016.4226. [Epub ahead of print]

Lewerenz J., Jarius S., Wildemann B., Wandinger K.P., Leypoldt F. [Autoantibody-associated autoimmune encephalitis and cerebellitis : Clinical presentation, diagnostic work-up and treatment]. Nervenarzt. 2016 Dec;87(12):1293-1299.

Kuhle J., Hardmeier M., Disanto G., Gugleta K., Ecsedi M., Lienert C., Amato M.P., Baum K., Buttmann M., Bayas A, Brassat D, Brochet B, Confavreux C, Edan G, Färkkilä M, Fredrikson S, Frontoni M., D'Hooghe M., Hutchinson M., De Keyser J., Kieseier B.C., Kümpfel T., Rio J., Polman C., Roullet E., Stolz C., Vass K., Wandinger K.P., Kappos L;. A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.European Long-term Follow-up Study Group in Interferon β-1b in Secondary-progressive Multiple Sclerosis.. Mult Scler. 2016 Apr;22(4):533-43. doi: 10.1177/1352458515594440.

Miske R., Gross C.C., Scharf M., Golombeck K.S., Hartwig M., Bhatia U., Schulte-Mecklenbeck A., Bönte K., Strippel C., Schöls L., Synofzik M., Lohmann H., Dettmann I.M., Deppe M., Mindorf S., Warnecke T., Denno Y., Teegen B., Probst C., Brakopp S., Wandinger K..P, Wiendl H., Stöcker W., Meuth S.G., Komorowski L., Melzer N. Neurochondrin is a neuronal target antigen in autoimmune cerebellar degeneration. Neurol Neuroimmunol Neuroinflamm. 2016 Dec 5;4(1):e307.

 

2015

Jarius S., Wildemann B., Stoecker W., Moser A., Wandinger, K.P. (2015) Psychotic syndrome associated with antibodies to ARHGAP26 and voltage-gated potassium channels. J. Neuroimmunol., Epub Jul 22

Kuhle J., Hardmeier M., Disanto G., Gugleta K., Ecsedi M., Lienert C., Amato M.P., Baum K., Bayas, A., Brassat D., Brochet B., Confavreux C., Edan G., Färkkilä M., Fasbender P., Fredrikson S., Frontoni M., D’Hooghe M., Hutchinson M., De Keyser J., Kieseier B.,  Kümpfel T., Laaksonen M., Rio J., Polman C., Roullet E., Vass K, Wandinger K.P., Kappos L., and the European Long Term Follow-up Study Group in Interferon β-1b in Secondary-Progressive MS. (2015) 10 year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive MS. Mult. Scler., Epub Sep 11

Höftberger R., van Sonderen A., Leypoldt F., Houghton D., Geschwind M., Gelfand J., Paredes M., Sabater L., Saiz A., Titulaer M.J., Graus F., Dalmau J. (2015) Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology 84 (24):2403-12. IF 8.303

Finke C., Kopp U.A., Pajkert A., Behrens J.R., Leypoldt F., Wuerfel J.T., Ploner C.J., Prüss H., Paul F. (2015) Structural hippocampal damage in anti-NMDAR encephalitis. Biological Psychiatry S0006-3223(15)00149-3. IF 9.472

Leypoldt F., Höftberger R.*, Titulaer M.J.*, Armangue T., Gresa-Arribas N., Jahn H.,  Rostasy K.,  Schlumberger W., Meyer T., Wandinger K.P., Rosenfeld M., Graus F., Dalmau J. (2015) CXCL13 is a biomarker of response to treatment and outcome in anti-NMDA-receptor encephalitis. JAMA Neurol. 72(2):180-6. IF 7.685   *gleichberechtigte Autorenschaft

Planagumà J.*, Leypoldt F.*, Mannara F., Gutiérrez-Cuesta J.,  Martín-García E., Aguilar E., Titulaer M.J., Jain A., Balice-Gordon R., Lakadamyali M., Graus F., Maldonado R. and Dalmau J. (2015) Human N-Methyl-D-aspartate receptor antibodies alter memory and behavior in mice. Brain 138(Pt 1):94-109. IF: 9.915  *gleichberechtigte Autorenschaft